# 2025-21501: Medicare Starts Bargaining for Cheaper Wonder Drugs

2025-21501, Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Final Guidance, is a Federal Register notice from Health and Human Services Department, Centers for Medicare & Medicaid Services published 2025-11-28, effective 2026-01-01; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-21501
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21501
- Title: Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Final Guidance
- Type: Notice
- Agencies: Health and Human Services Department; Centers for Medicare & Medicaid Services
- Citation: 90 FR 54692
- Published: 2025-11-28
- Effective: 2026-01-01
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Medicare Starts Bargaining for Cheaper Wonder Drugs

## Summary

Starting in 2026, Medicare will negotiate lower prices for some expensive drugs to help save money for patients and the government. This new rule affects drug makers, who must follow price limits through 2028, including a first-ever renegotiation cycle. These changes aim to make medicines more affordable while protecting certain special drugs, with clear deadlines and rules set by CMS.

## Abstract

The Centers for Medicare & Medicaid Services (CMS) is announcing the availability of CMS' final guidance for the third cycle of the Medicare Drug Price Negotiation Program (hereafter the "Negotiation Program"), the first cycle of renegotiation, and manufacturer effectuation of the maximum fair price (MFP) in 2026, 2027, and 2028 for the implementation of the Inflation Reduction Act of 2022 (IRA) (Pub. L. 117-169). This and other IRA-related guidance can be viewed on the dedicated IRA section of the CMS website at https:// www.cms.gov/inflation-reduction-act-and-medicare/

## Effects PRIA read

- Medicare drug price negotiations 2026–2028: benefit, medium. If you have Medicare, CMS will negotiate lower maximum fair prices for certain high‑cost, single‑source drugs starting in 2026. The final guidance covers manufacturer effectuation of those maximum fair prices in 2026, 2027, and 2028 and implements the Initial Price Applicability Year (IPAY) 2028 fr…

## Related documents

- [2026-22812](https://policyrisk.com/federal-register/2026-22812): Medicare and Medicaid Programs; Cutting Administrative Requirements for Excellence in Patient Care, 2026-11-10
- [2026-22750](https://policyrisk.com/federal-register/2026-22750): Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the E…, 2026-11-09
- [2026-22792](https://policyrisk.com/federal-register/2026-22792): Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program, 2026-11-09
- [2026-22743](https://policyrisk.com/federal-register/2026-22743): Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage…, 2026-11-09
- [2026-22739](https://policyrisk.com/federal-register/2026-22739): Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; i…, 2026-11-06
- [2026-22381](https://policyrisk.com/federal-register/2026-22381): Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage, 2026-11-03

## Sources
- [2025-21501 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/28/2025-21501/medicare-program-inflation-reduction-act-ira-medicare-drug-price-negotiation-program-final-guidance)
- [2025-21501 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-28/pdf/2025-21501.pdf)

## Related
- [Previous: 2025-21500, Renewals of Information Collections Under the Paperwork Reduction Act](https://policyrisk.com/federal-register/2025-21500)
- [Next: 2025-21502, Center for Scientific Review; Notice of Closed Meetings](https://policyrisk.com/federal-register/2025-21502)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21501 (as of 2026-06-08).
